Company attributes
Industry
B2X
CEO
Founder
Legal Name
EpicentRx, Inc.
Legal classification
Date Incorporated
2003
Number of Employees (Ranges)
11 – 50
Email Address
Phone Number
Full Address
11099 N Torrey Pines Rd, Ste 160, La Jolla, California, 92037, United States0
Founded Date
2024
0Total Funding Amount (USD)
35,000,000
Latest Funding Round Date
November 2019
Latest Funding Type
Patents Assigned (Count)
5
Country
Other attributes
Company Operating Status
Active
EpicentRX is a biotechnology company founded in 2002 that provides immuno-oncology solutions to oncology-specific problems. It provides its solutions using patented technology platforms and approaches to cancer treatment. EpicentRX develops minimally toxic cancer therapies for diverse patient populations and tumour types.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
